FDA Inspection 1231533 — Dermaceutical Laboratories, LLC

Dermaceutical Laboratories, LLC — FEI 3010164154

The FDA completed an inspection of Dermaceutical Laboratories, LLC on Mar 1, 2024 in Teterboro, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 1, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Teterboro, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.